APA (7th ed.) Citation

Makras, P., Yavropoulou, M. P., Polyzos, S. A., Papapoulos, S. E., Georgakopoulou, D., Papatheodorou, A., & Anastasilakis, A. D. (2024). The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection. Osteoporosis International, 35(2), 365. https://doi.org/10.1007/s00198-023-06931-3

Chicago Style (17th ed.) Citation

Makras, Polyzois, Maria P. Yavropoulou, Stergios A. Polyzos, Socrates E. Papapoulos, Danai Georgakopoulou, Athanasios Papatheodorou, and Athanasios D. Anastasilakis. "The Relationship Between Length of Denosumab Treatment for Postmenopausal Osteoporosis and Serum TRAcP5b Measured Six Months After the Last Injection." Osteoporosis International 35, no. 2 (2024): 365. https://doi.org/10.1007/s00198-023-06931-3.

MLA (9th ed.) Citation

Makras, Polyzois, et al. "The Relationship Between Length of Denosumab Treatment for Postmenopausal Osteoporosis and Serum TRAcP5b Measured Six Months After the Last Injection." Osteoporosis International, vol. 35, no. 2, 2024, p. 365, https://doi.org/10.1007/s00198-023-06931-3.